Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAALAD2 | Q9Y3Q0 | 5/20 | 0.66 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | CNR2 | P34972 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.53 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27694707 | 1.00 | NAALAD2 (0.66) | NAALAD2FOLH1GAACNR2MEN1 | |
| SCHEMBL6567538 | 1.00 | NAALAD2 (0.66) | NAALAD2FOLH1GAACNR2MEN1 | |
| SCHEMBL31499163 | 0.93 | NAALAD2 (0.58) | NAALAD2FOLH1GAACNR2MEN1 | |
| SCHEMBL4923938 | 0.92 | ALDH1A1 (0.60) | NAALAD2FOLH1GAAMEN1KMT2A | |
| SCHEMBL4923932 | 0.92 | ALDH1A1 (0.60) | NAALAD2FOLH1GAAMEN1KMT2A | |
| SCHEMBL9830029 | 0.91 | ATM (0.56) | NAALAD2FOLH1CNR2POLBATM | |
| SCHEMBL553992 | 0.88 | MMP12 (0.54) | NAALAD2CNR2MEN1KMT2AHDAC8 | |
| SCHEMBL14010459 | 0.88 | MMP12 (0.54) | NAALAD2CNR2MEN1KMT2AHDAC8 | |
| SCHEMBL236526 | 0.88 | KMT2A (0.58) | NAALAD2CNR2KMT2APOLB | |
| SCHEMBL236527 | 0.88 | KMT2A (0.58) | NAALAD2CNR2KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025123045-A1 | PREDICTIVE AND DIAGNOSTIC SCREENING METHODS FOR ENDOMETRIAL CANCER | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2025-06-12 | — | — | WO | claimed |
| US-20240290431-A1 | BIOMARKER AND DIAGNOSIS SYSTEM FOR COLORECTAL CANCER DETECTION | HANGZHOU CALIBRA DIAGNOSTICS CO LTD (CN) | 2024-08-29 | — | — | US | claimed |
| CN-117969853-A | Use of metabolic markers for the preparation of a product for assessing the risk of developing or complications of diabetes in an individual to be tested | 首都医科大学附属北京友谊医院 | 2024-05-03 | — | — | CN | claimed |
| CN-115436633-A | Biomarker for colorectal cancer detection and application thereof | 杭州凯莱谱精准医疗检测技术有限公司 | 2022-12-06 | — | — | CN | claimed |
| CN-115440375-A | Colorectal cancer prediction system and application thereof | 杭州凯莱谱精准医疗检测技术有限公司 | 2022-12-06 | — | — | CN | claimed |
| CN-114755422-A | Biomarker for colorectal cancer detection and application thereof | 杭州凯莱谱精准医疗检测技术有限公司 | 2022-07-15 | — | — | CN | claimed |
| CN-114758719-A | Colorectal cancer prediction system and application thereof | 杭州凯莱谱精准医疗检测技术有限公司 | 2022-07-15 | — | — | CN | claimed |
| US-20260076944-A1 | COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH | UNIV CALIFORNIA (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260034086-A1 | Pet Food Compositions Comprising Caprylic Acid And Docosahexaenoic Acid And/Or Eicosapetaenoic Acid For Use In Treating Struvite Urolithiasis | HILL'S PET NUTRITION, INC. (US) | 2026-02-05 | — | — | US | disclosed |
| CN-121164647-A | Method for determining biomarkers for BPH and severity discrimination thereof and discrimination system | 武汉大学中南医院 | 2025-12-19 | — | — | CN | disclosed |
| US-12458617-B2 | Pet food compositions comprising caprylic acid and docosahexaenoic acid and/or eicosapetaenoic acid for use in treating struvite urolithiasis | HILL'S PET NUTRITION, INC. (US) | 2025-11-04 | — | — | US | disclosed |
| EP-3709817-B2 | COMPOSITIONS COMPRISING OMEGA-3 POLYUNSATURATED AND MEDIUM CHAIN FATTY ACIDS | HILLS PET NUTRITION INC (US) | 2025-10-22 | — | — | EP | disclosed |
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | TEAM MEDICAL, LLC | 2025-09-18 | — | — | US | disclosed |
| US-5654333-A | THERAPY FOR ANEMIA, CANCER, AIDS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-08-05 | — | — | US | disclosed |
| US-5635533-A | ANTITUMOR AGENTS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-06-03 | — | — | US | disclosed |
| US-5635532-A | ADMINISTERING PHENYL OR NAPHTHYL ACETIC ACID DERIVATIVES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-06-03 | — | — | US | disclosed |
| US-5605930-A | ADMINISTERING PHENYLACETIC ACID AS AN INHIBITOR OF THE MEVALONATE PATHWAY | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-02-25 | — | — | US | disclosed |
| EP-0567613-A4 | COMPOSITIONS AND METHODS FOR THERAPY AND PREVENTION OF CANCER, AIDS, AND ANEMIA | SAMID DVORIT (US) | 1996-03-13 | — | — | EP | disclosed |
| EP-0567613-A1 | COMPOSITIONS AND METHODS FOR THERAPY AND PREVENTION OF CANCER, AIDS, AND ANEMIA | SAMID, Dvorit (US) | 1993-11-03 | — | — | EP | disclosed |
| WO-1993007866-A2 | COMPOSITIONS AND METHODS FOR THERAPY AND PREVENTION OF CANCER, AIDS, AND ANEMIA | SAMID DVORIT (US) | 1993-04-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034086-A1 | Pet Food Compositions Comprising Caprylic Acid And Docosahexaenoic Acid And/Or Eicosapetaenoic Acid For Use In Treating Struvite Urolithiasis | FPR2, FPR1, FPR3 | NAALAD2 441/4885FOLH1 21/4885GAA 2120/4885 |
| US-20260076944-A1 | COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH | IDO1, INMT, IDO2 | NAALAD2 124/4885FOLH1 3785/4885GAA 4441/4885 |
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | SYNCRIP, SNRPA, RNASE1 | NAALAD2 3794/4885FOLH1 2682/4885GAA 209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.